# NG-TEST Candida auris

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/ng-test-candida-auris
Canonical HTML page: https://getbiobrief.com/entity/ng-test-candida-auris

## Recent coverage (1 stories)

### NG Biotech and Hardy Diagnostics Secure FDA Breakthrough Status for AMR Assays
2026-02-19 11:10:32 · Sentiment: Positive · Impact: 7/10 · Sources: 2

NG Biotech and partner Hardy Diagnostics have received FDA Breakthrough Device Designation for two rapid diagnostic tests targeting Candida auris and Acinetobacter baumannii. These assays aim to provide near-instant identification of high-priority antimicrobial-resistant pathogens to improve hospital infection control.
Full story: https://getbiobrief.com/story/ng-biotech-hardy-diagnostics-fda-breakthrough-amr

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.